Format
Sort by

Send to:

Choose Destination

Results: 4

1.

[Central nervous system malformations and the presence of the MTHFR-C677T mutation in fetal blood].

Simoni RZ, Couto E, Barini R, Heinrich-Moçouçah J, Bragança WO, Couto ER, Bizzachi JM.

Rev Bras Ginecol Obstet. 2013 Oct;35(10):436-41. Portuguese.

2.

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P, Goldhaber SZ; RE-MEDY Trial Investigators; RE-SONATE Trial Investigators.

N Engl J Med. 2013 Feb 21;368(8):709-18. doi: 10.1056/NEJMoa1113697.

3.

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.

Lopes RD, Becker RC, Alexander JH, Armstrong PW, Califf RM, Chan MY, Crowther M, Granger CB, Harrington RA, Hylek EM, James SK, Jolicoeur EM, Mahaffey KW, Newby LK, Peterson ED, Pieper KS, Van de Werf F, Wallentin L, White HD, Carvalho AC, Giraldez RR, Guimaraes HP, Nader HB, Kalil RA, Bizzachi JM, Lopes AC, Garcia DA.

J Thromb Thrombolysis. 2011 Aug;32(2):242-66. doi: 10.1007/s11239-011-0592-7.

PMID:
21547405
4.

Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ; RE-COVER Study Group.

N Engl J Med. 2009 Dec 10;361(24):2342-52. doi: 10.1056/NEJMoa0906598. Epub .

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk